Mulmit

BIO-TECHNE CorpBIO-TECHNE Corp

TECH Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2026-06-301,215,039,000251,890,0001.16
2025-06-301,219,635,000102,255,00073,400,0000.46
2024-06-301,159,060,000206,686,000168,105,0001.05
2023-06-301,136,702,000298,944,000285,263,0001.76
2022-06-301,105,599,000296,590,000272,051,0001.66

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-17Bohnen ShaneSVP - General Counsel11,344
2026-08-17Bohnen ShaneSVP - General Counsel18,432
2026-08-17Kelderman KimChief Executive Officer57,590
2026-08-17Kelderman KimChief Executive Officer93,582
2026-08-17Hippel JamesCFO22,438
2026-08-17Hippel JamesCFO36,459
2026-08-17Herr Amy E.1,381
2026-08-17Geist WilliamPRESIDENT, PROTEIN SCIENCES14,762
2026-08-17Geist WilliamPRESIDENT, PROTEIN SCIENCES23,985
2026-08-17Crouse Steven C.President - Diag & Spatial Bi8,702
2026-08-17Crouse Steven C.President - Diag & Spatial Bi14,140
2026-08-15Kelderman KimChief Executive Officer21,470

8-K events

FiledItems
2026-08-12Results of operations · Other events · Financial statements and exhibits
2026-06-26Entry into a material agreement · Officer or director change · Financial statements and exhibits
2026-06-25Regulation FD disclosure · Financial statements and exhibits
2026-05-06Results of operations · Other events · Financial statements and exhibits
2026-02-11Officer or director change · Other events · Financial statements and exhibits
2026-02-04Results of operations · Other events · Financial statements and exhibits
2025-11-05Results of operations · Submission of matters to a vote · Other events · Financial statements and exhibits
2025-08-06Results of operations · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.